- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Trastuzumab – July 2015
Trastuzumab; solution for subcutaneous injection, 600 mg/5 mL, 1; Herceptin®
Last updated
1 November 2015